Xcel Energy Inc XEL Q1 2026 Earnings Preview Growth Trajectory Meets Mixed Beat Probability Vertex Pharmaceuticals Incorporated VRTX Casgevy Commercial Momentum and Pipeline Catalysts Signal Upside Ahead of Partner CRISPR Therapeutics Q1 2026 Earnings FSBC Five Star posts a 68 percent Q4 2025 EPS beat as its stock slips 052 percent in todays session